HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.

AbstractBACKGROUND:
Dipeptidyl-peptidase IV (EC 3.4.14.5) (DPPIV) is a serine peptidase involved in cell differentiation, adhesion, immune modulation and apoptosis, functions that control neoplastic transformation. Previous studies have demonstrated altered expression and activity of tissue and circulating DPPIV in several cancers and proposed its potential usefulness for early diagnosis in colorectal cancer (CRC).
METHODS AND PRINCIPAL FINDINGS:
The activity and mRNA and protein expression of DPPIV was prospectively analyzed in adenocarcinomas, adenomas, uninvolved colorectal mucosa and plasma from 116 CRC patients by fluorimetric, quantitative RT-PCR and immunohistochemical methods. Results were correlated with the most important classic pathological data related to aggressiveness and with 5-year survival rates. Results showed that: 1) mRNA levels and activity of DPPIV increased in colorectal neoplasms (Kruskal-Wallis test, p<0.01); 2) Both adenomas and CRCs displayed positive cytoplasmic immunostaining with luminal membrane reinforcement; 3) Plasmatic DPPIV activity was lower in CRC patients than in healthy subjects (Mann-U test, p<0.01); 4) Plasmatic DPPIV activity was associated with worse overall and disease-free survivals (log-rank p<0.01, Cox analysis p<0.01).
CONCLUSION/SIGNIFICANCE:
1) Up-regulation of DPPIV in colorectal tumors suggests a role for this enzyme in the neoplastic transformation of colorectal tissues. This finding opens the possibility for new therapeutic targets in these patients. 2) Plasmatic DPPIV is an independent prognostic factor in survival of CRC patients. The determination of DPPIV activity levels in the plasma may be a safe, minimally invasive and inexpensive way to define the aggressiveness of CRC in daily practice.
AuthorsGorka Larrinaga, Itxaro Perez, Begoña Sanz, Maider Beitia, Peio Errarte, Ainhoa Fernández, Lorena Blanco, María C Etxezarraga, Javier Gil, José I López
JournalPloS one (PLoS One) Vol. 10 Issue 3 Pg. e0119436 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID25790122 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • RNA, Messenger
  • Dipeptidyl Peptidase 4
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Apoptosis (genetics)
  • Biomarkers, Tumor (biosynthesis, genetics)
  • Colorectal Neoplasms (blood, genetics, pathology)
  • Dipeptidyl Peptidase 4 (biosynthesis, blood, genetics)
  • Disease-Free Survival
  • Early Detection of Cancer
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • RNA, Messenger (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: